结核病诊断的最新进展综述

S. Parveen, D. Arya
{"title":"结核病诊断的最新进展综述","authors":"S. Parveen, D. Arya","doi":"10.21276/IJLSSR.2018.4.1.8","DOIUrl":null,"url":null,"abstract":"Globally tuberculosis remains a challenge from the point of diagnosis, detection of drug resistance, and treatment. Treatment can only be initiated, when infection is detected and it’s based on the results of AST, recently there has been a marked increase in the development and testing of novel assays designed to detect Mycobacterium tuberculosis. Although most important advances that would develop tuberculosis (TB) analysis have not been realized, we are beginning to see the innovations that have been prompted by the recognition of the economic potential of the market for new diagnostic tests for TB and considerably increased public and private funding and awareness. In this present review, we focused on the newer tests that are accessible for the analysis of suppressed and active tuberculosis and rapid detection of drug resistance, nucleic acid amplification for identification of M. tuberculosis complex, and rapid tests for detecting drug resistance. PCR-based technologies and hybridization assays used for the recognition of the mycobacteria. Though these newer techniques are useful for a rapid result, emphasizing that culture-based diagnosis is still the ‘gold standard’ for the diagnosis and follows up on tuberculosis. Key-wordsDrug Sensitivity Testing (DST), M. tuberculosis, Molecular diagnosis, Tuberculosis infection, PCR, INTRODUCTION Tuberculosis (TB) is one of the leading infectious diseases in the world and is responsible for more than 2 million deaths and 8 million new cases annually [1] and in India, accounts for one-fifth of this global burden of TB . The disease is caused by a bacterium called M. tuberculosis. The bacteria usually attack the lungs, but can infect any part of the body such as the kidney, intestine, pleura, spine, and brain. If not treated properly, this infectious disease can be fatal . TB and HIV have been closely linked since the emergence of AIDS and both diseases is a major public health challenge. It is estimated that 60-70% of HIV positive persons will develop tuberculosis in their lifetime . Smear microscopy has suboptimal sensitivity and detects only about 60-70% of the TB cases. The implementation of culture for the diagnosis can improve the TB detection rate of a laboratory by about 30-40%. These two laboratory methods, smear microscopy and culture are still the “gold standards” for the diagnosis of TB and culture is considered as the most sensitive method. Access this article online Quick Response Code Website:","PeriodicalId":22509,"journal":{"name":"The International Journal of Life-Sciences Scientific Research","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Recent Advances in Diagnosis of Tuberculosis: A Review\",\"authors\":\"S. Parveen, D. Arya\",\"doi\":\"10.21276/IJLSSR.2018.4.1.8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Globally tuberculosis remains a challenge from the point of diagnosis, detection of drug resistance, and treatment. Treatment can only be initiated, when infection is detected and it’s based on the results of AST, recently there has been a marked increase in the development and testing of novel assays designed to detect Mycobacterium tuberculosis. Although most important advances that would develop tuberculosis (TB) analysis have not been realized, we are beginning to see the innovations that have been prompted by the recognition of the economic potential of the market for new diagnostic tests for TB and considerably increased public and private funding and awareness. In this present review, we focused on the newer tests that are accessible for the analysis of suppressed and active tuberculosis and rapid detection of drug resistance, nucleic acid amplification for identification of M. tuberculosis complex, and rapid tests for detecting drug resistance. PCR-based technologies and hybridization assays used for the recognition of the mycobacteria. Though these newer techniques are useful for a rapid result, emphasizing that culture-based diagnosis is still the ‘gold standard’ for the diagnosis and follows up on tuberculosis. Key-wordsDrug Sensitivity Testing (DST), M. tuberculosis, Molecular diagnosis, Tuberculosis infection, PCR, INTRODUCTION Tuberculosis (TB) is one of the leading infectious diseases in the world and is responsible for more than 2 million deaths and 8 million new cases annually [1] and in India, accounts for one-fifth of this global burden of TB . The disease is caused by a bacterium called M. tuberculosis. The bacteria usually attack the lungs, but can infect any part of the body such as the kidney, intestine, pleura, spine, and brain. If not treated properly, this infectious disease can be fatal . TB and HIV have been closely linked since the emergence of AIDS and both diseases is a major public health challenge. It is estimated that 60-70% of HIV positive persons will develop tuberculosis in their lifetime . Smear microscopy has suboptimal sensitivity and detects only about 60-70% of the TB cases. The implementation of culture for the diagnosis can improve the TB detection rate of a laboratory by about 30-40%. These two laboratory methods, smear microscopy and culture are still the “gold standards” for the diagnosis of TB and culture is considered as the most sensitive method. Access this article online Quick Response Code Website:\",\"PeriodicalId\":22509,\"journal\":{\"name\":\"The International Journal of Life-Sciences Scientific Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The International Journal of Life-Sciences Scientific Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21276/IJLSSR.2018.4.1.8\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The International Journal of Life-Sciences Scientific Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21276/IJLSSR.2018.4.1.8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

从诊断、发现耐药性和治疗的角度来看,全球结核病仍然是一个挑战。只有在检测到感染时才能开始治疗,治疗是基于AST的结果,最近,用于检测结核分枝杆菌的新型检测方法的开发和测试有了显著的增加。虽然发展结核病分析的最重要进展尚未实现,但由于认识到结核病新诊断检测市场的经济潜力,以及公共和私人供资和认识的大幅增加,我们开始看到推动创新的出现。在这篇综述中,我们重点介绍了用于抑制和活动性结核病分析和快速检测耐药性的最新检测方法,用于鉴定结核分枝杆菌复合体的核酸扩增方法,以及用于检测耐药性的快速检测方法。基于pcr的技术和杂交分析用于分枝杆菌的识别。虽然这些较新的技术有助于快速取得结果,但强调基于培养的诊断仍然是结核病诊断和随访的“金标准”。结核病(TB)是世界上主要的传染病之一,每年造成200多万人死亡,800万新发病例[1],在印度,结核病占全球结核病负担的五分之一。这种疾病是由一种叫做结核分枝杆菌的细菌引起的。这种细菌通常攻击肺部,但也可以感染身体的任何部位,如肾脏、肠道、胸膜、脊柱和大脑。如果治疗不当,这种传染病可能是致命的。自艾滋病出现以来,结核病和艾滋病毒一直密切相关,这两种疾病都是一项重大的公共卫生挑战。据估计,60-70%的艾滋病毒阳性者将在其一生中发展为结核病。涂片镜检的灵敏度不够理想,只能检测到约60-70%的结核病病例。实施培养诊断可使实验室的结核病检出率提高约30-40%。涂片镜检和培养这两种实验室方法仍然是诊断结核病的“金标准”,培养被认为是最敏感的方法。在线阅读本文快速响应代码网站:
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Recent Advances in Diagnosis of Tuberculosis: A Review
Globally tuberculosis remains a challenge from the point of diagnosis, detection of drug resistance, and treatment. Treatment can only be initiated, when infection is detected and it’s based on the results of AST, recently there has been a marked increase in the development and testing of novel assays designed to detect Mycobacterium tuberculosis. Although most important advances that would develop tuberculosis (TB) analysis have not been realized, we are beginning to see the innovations that have been prompted by the recognition of the economic potential of the market for new diagnostic tests for TB and considerably increased public and private funding and awareness. In this present review, we focused on the newer tests that are accessible for the analysis of suppressed and active tuberculosis and rapid detection of drug resistance, nucleic acid amplification for identification of M. tuberculosis complex, and rapid tests for detecting drug resistance. PCR-based technologies and hybridization assays used for the recognition of the mycobacteria. Though these newer techniques are useful for a rapid result, emphasizing that culture-based diagnosis is still the ‘gold standard’ for the diagnosis and follows up on tuberculosis. Key-wordsDrug Sensitivity Testing (DST), M. tuberculosis, Molecular diagnosis, Tuberculosis infection, PCR, INTRODUCTION Tuberculosis (TB) is one of the leading infectious diseases in the world and is responsible for more than 2 million deaths and 8 million new cases annually [1] and in India, accounts for one-fifth of this global burden of TB . The disease is caused by a bacterium called M. tuberculosis. The bacteria usually attack the lungs, but can infect any part of the body such as the kidney, intestine, pleura, spine, and brain. If not treated properly, this infectious disease can be fatal . TB and HIV have been closely linked since the emergence of AIDS and both diseases is a major public health challenge. It is estimated that 60-70% of HIV positive persons will develop tuberculosis in their lifetime . Smear microscopy has suboptimal sensitivity and detects only about 60-70% of the TB cases. The implementation of culture for the diagnosis can improve the TB detection rate of a laboratory by about 30-40%. These two laboratory methods, smear microscopy and culture are still the “gold standards” for the diagnosis of TB and culture is considered as the most sensitive method. Access this article online Quick Response Code Website:
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信